Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial

2012131 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 14, Issue 1, pp. 88-96

Field-Weighted Citation Impact: 7.57